Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FBXO36 intronic transcript 1 (FBXO36-IT1) is a long non-coding RNA (lncRNA) gene located within the locus of the F-box protein 36 (FBXO36) gene. It is classified as a non-protein coding transcript (lncRNA) and does not encode a protein product. Current public resources do not link FBXO36-IT1 to any biological functions, disease roles, or therapeutic targeting, and there are no known interacting drugs or biomarker uses. The transcript may represent a retained intron or alternative non-coding transcript from the FBXO36 locus, but there is no evidence to support its role as a human therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FBXO36 intronic transcript 1 (FBXO36-IT1).